We are initiating coverage on Abacus Health Products, a consumer healthcare company that currently sells topical hemp-derived cannabidiol (CBD) in combination with active pharmaceutical ingredients that have known efficacy to treat indications such as pain, acne and itch. This allows Abacus to make specific medical claims about the efficacy of its products without having to claim that CBD itself is efficacious.Den vollständigen Artikel lesen ...
© 2019 Edison Investment Research